Home Business Page 7

Business

New collaboration for Kite and Sangamo

A drug-linker technology to fight cancer

A new drug discovery initiative by Pfizer

A strategic partnership to produce certain US DEA controlled substances

Completed the acquisition of Juno Therapeutics

A new partnership to treat Sma

Rare diseases. Orphan drug market

A licenseng agreement to develop new materials for immuno-oncology therapies

A new accelerated drug development service

A partnership to neutralize interferon-alpha

1...678...29Page 7 of 29
© © 2025 Tecniche Nuove Spa - All rights reserved. Registered office: Via Eritrea 21 - 20157 Milan. Share capital: 5,000,000 Euro fully paid up. Tax code, VAT number and registration with the Milan Register of Companies: 00753480151